GLP-1 Insurance Coverage Checker
Will your insurance cover Ozempic, Wegovy, Zepbound, or Mounjaro?
Find out how likely your insurance is to approve your GLP-1 prescription based on your medication, diagnosis, BMI, insurance plan, and prior authorization requirements.
In under 30 seconds you'll receive:
- Your estimated coverage chance (High, Medium, or Low)
- Whether prior authorization is likely required
- Your estimated copay range if approved
- Your appeal strength if denied
- Personalized next steps to improve your approval odds
Insurance is much more likely to approve a GLP-1 when it is prescribed for its FDA-approved use. Most commercial plans require prior authorization, Medicare generally cannot cover a medication prescribed only for weight loss, Medicaid rules vary by state, and employer plans differ widely.
| Your situation | Typical monthly cost |
|---|---|
| Ozempic | Type 2 diabetes |
| Mounjaro | Type 2 diabetes |
| Wegovy | Chronic weight management |
| Zepbound | Chronic weight management |
Prescribing outside these approved uses is the single most common reason a GLP-1 claim is denied.
Your approval depends on four key factors
- The medication prescribed
- Why it was prescribed
- Your insurance plan
- Your BMI and related medical conditions
Insurance coverage checker
Answer five questions for a personalized estimate, the most likely decision your plan will return, and an action plan for either outcome.
What this checker measures
This checker estimates how likely a typical U.S. insurance plan is to approve your GLP-1 prescription, using the same factors insurers commonly evaluate during prior authorization. Rather than a simple yes or no, it explains why your result looks the way it does.
Your personalized result includes:
- Coverage chance
- Estimated copay range
- Prior authorization likelihood
- Appeal strength if denied
- Most likely reason for denial
- Recommended next steps
The most common reasons insurance denies GLP-1 coverage
Most first-time denials come down to a short list of causes — and several of them are paperwork problems that can be fixed and resubmitted.
- Off-label prescribing
- Weight-loss exclusion in your plan
- Missing prior authorization documentation
- BMI below plan requirements
- Missing obesity-related condition
- Step therapy not completed
- Drug not on formulary
- Incomplete physician paperwork
- Missing Letter of Medical Necessity
- No documented lifestyle program
Coverage odds by situation
| Your situation | Typical monthly cost |
|---|---|
| Type 2 diabetes | High |
| BMI ≥ 30 | Medium–High |
| BMI ≥ 27 + comorbidity | Medium |
| Weight loss only | Depends on plan |
| Off-label use | Low |
| PCOS | Low |
| Cosmetic weight loss | Very low |
Educational estimates based on published FDA indications and commonly documented payer criteria. Your plan's own rules govern.
How the estimate works
The checker evaluates the four major factors most insurers apply.
1. Drug and diagnosis match
On-label prescriptions receive the highest approval probability.
2. Insurance type
Commercial plans generally offer broader coverage than Medicare. Employer plans vary significantly, and Medicaid rules depend on your state.
3. Medical eligibility
For weight-management medications, insurers commonly review:
- BMI
- Weight-related medical conditions
- Previous treatment attempts
4. Prior authorization
Most GLP-1 medications require prior authorization before coverage begins. Incomplete submissions are among the most common reasons for an initial denial.
Medical criteria insurers commonly use
| Indication | Typical requirement | FDA-approved drugs |
|---|---|---|
| Type 2 diabetes | Confirmed diagnosis (A1c / labs), sometimes metformin tried first | Ozempic, Mounjaro, Rybelsus |
| Obesity | BMI ≥ 30 | Wegovy, Zepbound |
| Overweight + condition | BMI ≥ 27 plus a weight-related condition | Wegovy, Zepbound |
| PCOS | No GLP-1 is FDA-approved for PCOS — always off-label | — |
Before your doctor submits prior authorization
Most first denials are documentation failures rather than clinical judgements. Gathering these first is the highest-value thing you can do.
- Confirm the preferred GLP-1 on your formulary
- Document your BMI in the medical record
- Document related health conditions
- Record previous weight-loss attempts
- Gather previous medication history
- Include recent lab results if applicable
- Request a Letter of Medical Necessity
If you're denied
A first denial is not the end of the process. What matters is which denial you received, because each type has a different route out.
Prior authorization denied
- 1Request the denial reason in writing
- 2Correct the missing documentation
- 3Resubmit, then appeal if denied again
Formulary exclusion
- 1Request a formulary exception
- 2Include clinical justification from your prescriber
- 3Ask which covered alternative your plan prefers
Weight-loss exclusion
- 1Confirm whether the exclusion is statutory or plan-level
- 2Ask whether a separate approved indication applies
- 3Estimate cash-pay options as the realistic route
Step therapy
- 1Document the medications you have already tried
- 2Request a step-therapy override if those failed
- 3Resubmit with that history attached
How to improve your approval odds
- Use the medication approved for your diagnosis. If your goal is weight, ask about Wegovy or Zepbound rather than Ozempic.
- Document BMI accurately in the medical record — self-reported numbers do not count.
- Include obesity-related conditions. At a BMI of 27–30, a documented condition is often what unlocks coverage.
- Document lifestyle changes and any structured nutrition program.
- Complete prior authorization carefully — incomplete forms are the top cause of first denials.
- Ask whether your plan requires step therapy before it will pay.
- Request a Letter of Medical Necessity from your prescriber.
- Appeal if documentation was incomplete — that is the most winnable kind of denial.
Real-life example
Clinical considerations
Coverage rules change often and vary by employer, state Medicaid program, and plan year. Newer FDA approvals — semaglutide for cardiovascular risk reduction, tirzepatide for obstructive sleep apnea — are gradually widening what Medicare and commercial plans will pay for, and they are sometimes the only route to coverage where a weight-loss exclusion applies.
Confirm your plan's current formulary and criteria, and let your prescriber lead the decision about which medication is clinically right for you.
Frequently asked questions
Common questions and answers about this calculator.
Why was my Ozempic claim denied for weight loss?
Ozempic is FDA-approved for type 2 diabetes, not weight loss. When it is prescribed purely for weight loss, most plans treat it as off-label and deny it. Wegovy contains the same active ingredient (semaglutide) but is approved for chronic weight management, so it is usually the covered path for that goal.
Does Medicare ever cover GLP-1 medications?
Yes — for type 2 diabetes, and for other FDA-approved medical conditions such as cardiovascular risk reduction with Wegovy or obstructive sleep apnea with Zepbound. Medicare Part D is generally prohibited from covering a medication used only for weight loss.
What BMI do most insurance plans require?
Most plans require a BMI of 30 or higher, or 27 or higher if you also have a weight-related condition such as hypertension, high cholesterol, sleep apnea, or prediabetes. Your BMI must be documented in your medical record, not self-reported.
Does insurance cover GLP-1 medications for PCOS?
No GLP-1 is FDA-approved specifically for PCOS, so a PCOS-only request is off-label and usually denied on that basis. Coverage may still be possible if you separately meet criteria for type 2 diabetes or qualifying obesity.
How long does prior authorization usually take?
Typically three to ten business days once your prescriber submits complete documentation, though Medicaid can take longer. Missing information is the most common cause of both delay and first-round denial.
Is it worth appealing a denial?
Often yes, particularly when the use is on-label and the denial was a documentation problem. Appeals are least likely to succeed against a firm plan exclusion, such as Medicare's statutory weight-loss exclusion.
What documents improve prior authorization approval?
Documented BMI with height and weight, confirmed diagnosis codes, any weight-related conditions, a history of previous weight-loss or medication attempts, relevant labs, and a Letter of Medical Necessity from your prescriber.
What is step therapy?
Step therapy is a plan rule requiring you to try one or more lower-cost medications first before it will pay for the one you were prescribed. If you have already tried and failed those medications, that history can support a step-therapy override.
What is the difference between a prior authorization denial and a formulary exclusion?
A prior authorization denial means the drug is covered in principle but you have not yet met the plan's criteria, so correcting the documentation and resubmitting often works. A formulary exclusion means the plan does not cover that drug at all, which requires a formulary exception request rather than a standard appeal.
Will switching from Ozempic to Wegovy improve my approval chances?
For a weight-management goal, usually yes, because Wegovy is FDA-approved for that use while Ozempic is not. Whether the switch is clinically appropriate is a decision for your prescriber, not a coverage tactic.
Can my employer exclude weight-loss medications?
Yes. Self-funded employer plans can exclude weight-management drugs entirely, which is why two people with the same insurance company can get different answers. Ask your benefits administrator whether your plan includes the benefit at all.
Does my doctor need to write a Letter of Medical Necessity?
It is not always required, but it materially strengthens a request — especially at a BMI of 27–30, after a previous denial, or when asking for a formulary exception. It should state your diagnosis, history, and why alternatives are unsuitable.
Related tools and when to use them
| Tool | When to use it |
|---|---|
| GLP-1 Cost Calculator | Estimate your monthly cost if approved, or if you end up paying cash. |
| GLP-1 Savings Calculator | Add manufacturer savings cards, HSA or FSA dollars, and pharmacy coupons. |
| GLP-1 Eligibility Checker | Confirm whether you medically qualify before requesting coverage. |
| GLP-1 Cost & Access Center | The full hub — eligibility, coverage, pricing, and appeals in one place. |
References
- U.S. Food & Drug Administration — approved labeling and indications for semaglutide, tirzepatide, and liraglutide products.
- Centers for Medicare & Medicaid Services — Part D coverage rules and the statutory weight-loss exclusion.
- Manufacturer prescribing information — NovoCare (Ozempic, Wegovy, Rybelsus, Saxenda) and Lilly (Mounjaro, Zepbound).
Tool Information
July 28, 2026
Dr. Jaydeep Sanghani
Meet Akabari
Dr. Jaydeep Sanghani
MBBS, MD, DNB(Anaesth.), PDCC(CCM), DrNB(CCM)
AIIMS Bhubaneswar · AIIMS Rishikesh
Critical care specialist and anesthesiologist with advanced training from AIIMS. Reviews health calculators at Calqulate to ensure medical accuracy and evidence-based standards.